L-R: Emily Nikolić, Agathe Michel-de Cazotte, Daniel Wise from Carpmaels & Ransford.
16 July 2024NewsUnified Patent CourtMarisa Woutersen
Sanofi and Regeneron triumph in UPC decision against Amgen
UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
9 July 2024 Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | DexCom and Abbott dispute over technology for remotely monitoring blood glucose levels in diabetes patients.
30 October 2020 French drugmaker Sanofi and US biotechnology company Regeneron have secured a victory at the European Patent Office, which has sided in their favour by ruling that a patent belonging to rival Amgen is invalid.